Additionally, our data showed that most patients had a lower TMB, with a median value of 6.3 mutations per megabase (mut/Mb), which aligns with the notion that patients with BRAF mutant NSCLC may tend to have a lower or intermediate TMB and microsatellite stability (24). The gene discussed is BRAF; the disease is non-small cell lung carcinoma.